Balyasny Asset Management LLC Nuvation Bio Inc. Transaction History

Balyasny Asset Management LLC

  • $54.9 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$1.68 - $2.5 $74,084 - $110,245
44,098 New
44,098 $84,000
Q2 2021

Aug 16, 2021
SELL
$9.22 - $14.48 $199,539 - $313,376
-21,642 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$9.0 - $14.57 $194,778 - $315,323
21,642 New
21,642 $226,000

Others Institutions Holding NUVB

# of Institutions
152
Shares Held
123M
Call Options Held
9.7K
Put Options Held
6.5K
View Full List

About Nuvation Bio Inc.

NUVB Quotes by TradingView
  • Ticker NUVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 217,244,000
  • Market Cap $480M
  • Description
  • Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...
More about NUVB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email